Trial intelligence / Profile preview

Dexmedetomidine vs Fentanyl for Postoperative Neonatal Sedation

NCT05324891Phase 2Completed

Sponsor
Mansoura University
Start
Jan 2016
Primary completion
Aug 2017
Modality
Small Molecules
01

Overview

Phase 2, randomised trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Mansoura University. Primary endpoint: Efficacy of postoperative sedation according to pain score up to 5 days. Started Jan 2016; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05324891.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05324891.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call